GlassScriptPhysician profile
Ann Coon Sims
NPI 1346927647
$1,334.53
in general payments reported to CMS, 2019-2025
20 companies · $671 in 2025
The $671 reported for 2025 was more than what 76% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $663 · 2025: $671.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,235 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,234.54 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $207.44 | 2024-2025 | Dexcom G6 Transmitter, Dexcom G7 Gss (161) |
| Janssen Biotech, INC. | $162.65 | 2025 | Erleada |
| Sumitomo Pharma America, INC. | $134.98 | 2025 | Gemtesa, Orgovyx |
| Lilly USA, LLC | $131.63 | 2024 | Mounjaro, Zepbound |
| Novo Nordisk INC | $127.81 | 2024 | Wegovy, Rybelsus |
| Vanda Pharmaceuticals INC. | $92.36 | 2024-2025 | Fanapt |
| Immunitybio, INC. | $69.44 | 2025 | |
| Indivior INC. | $60.40 | 2024 | Sublocade |
| Bayer Healthcare Pharmaceuticals INC. | $60.12 | 2024-2025 | |
| Otsuka America Pharmaceutical, INC. | $56.45 | 2024 | Rexulti |
| Averitas Pharma INC. | $38.19 | 2024 | Qutenza |
| Merck Sharp & Dohme LLC | $32.47 | 2024-2025 | Capvaxive |
| Amgen INC. | $27.35 | 2024 | Repatha, Otezla |
| 180 Medical, INC. | $22.98 | 2025 | Gentlecath |
| Endo USA, INC. | $22.79 | 2025 | Xiaflex |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $21.97 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $20.14 | 2025 | Austedo Xr |
| Exact Sciences Corporation | $15.66 | 2024 | Cologuard Collection Kit |
| Lundbeck LLC | $15.11 | 2025 | Rexulti |
| Astrazeneca Pharmaceuticals LP | $14.59 | 2024 | Breztri |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Sims listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.